Physician

James E. Carinder, DO

According to 2025 Medicare claims, James Carinder, DO (NPI: 1508821372) practices hematology/oncology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70433-3661. Carinder is affiliated with the Hattiesburg Clinic ACO (ACO ID: A2880), participating under the MSSP model.

Carinder's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 420 traditional Medicare patients, billed 160,805 HCPCS/CPT codes, and received $3,105,086 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,748 prescription claims across 220 beneficiaries totaling $4,455,330 in drug costs, led by Revlimid (Lenalidomide). 2020 DME data shows 11 claims. Open Payments data shows 134 records totaling $2,795. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $104,047 to $3,105,086. Similarly, Part D prescription costs have risen steadily, from $1,440,720 to $4,455,330. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,172 to $1,084.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $104,047 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $94,654 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $79,460 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $87,166 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $86,536 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $133,652 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,471,964 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,381,146 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,684,743 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,105,086 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153891,676$104,047
20164051,532$94,654
20173471,257$79,460
20184601,296$87,166
20194091,287$86,536
20206221,951$133,652
202145874,217$1,471,964
2022438171,691$3,381,146
2023440159,150$2,684,743
2024420160,805$3,105,086

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.2M$4.5M2015 Drug cost: $1,440,720 (USD; Tot_Drug_Cst)2016 Drug cost: $2,584,757 (USD; Tot_Drug_Cst)2017 Drug cost: $2,881,527 (USD; Tot_Drug_Cst)2018 Drug cost: $3,379,382 (USD; Tot_Drug_Cst)2019 Drug cost: $2,759,631 (USD; Tot_Drug_Cst)2020 Drug cost: $3,210,091 (USD; Tot_Drug_Cst)2021 Drug cost: $3,522,714 (USD; Tot_Drug_Cst)2022 Drug cost: $3,800,955 (USD; Tot_Drug_Cst)2023 Drug cost: $3,639,401 (USD; Tot_Drug_Cst)2024 Drug cost: $4,455,330 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153082,697$1,440,720
20163032,679$2,584,757
20173012,686$2,881,527
20183292,720$3,379,382
20193242,951$2,759,631
20203242,748$3,210,091
20212461,964$3,522,714
20222372,050$3,800,955
20232241,968$3,639,401
20242201,748$4,455,330

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$2.0K$4.0K2015 Medicare payment: $691 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $520 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,980 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,908 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R12$691
2016N/R12$520
2017N/RN/RN/R
2018N/RN/RN/R
2019N/R29$3,980
2020N/R11$1,908
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more172577$123
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4246$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more204445$59
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less43185$43
36415Insertion of needle into vein for collection of blood sample158821$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RevlimidLenalidomide581,519$1,043,902
TasignaNilotinib Hcl35980$688,791
LenalidomideLenalidomide401,078$545,270
ImbruvicaIbrutinib26732$395,745
VenclextaVenetoclax21626$313,055

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.134$2,795Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for James E. Carinder, DO?

Tedicare shows public-source Medicare data for James E. Carinder, DO (NPI 1508821372), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James E. Carinder, DO have ACO affiliation data?

James E. Carinder, DO is shown with ACO affiliation data for Hattiesburg Clinic ACO (MSSP, ACO ID A2880).

What billing organization is linked to James E. Carinder, DO?

James E. Carinder, DO is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does James E. Carinder, DO have Open Payments data?

James E. Carinder, DO has 134 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.